NCT00004197View on ClinicalTrials.gov

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 25, 1999

Primary Completion Date

January 1, 2002

Study Completion Date

November 20, 2003

Conditions
Lymphoma
Interventions
BIOLOGICAL

keyhole limpet hemocyanin

BIOLOGICAL

sargramostim

BIOLOGICAL

tumor cell-based vaccine therapy

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

mitoxantrone hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (2)

94305-5408

Stanford University Medical Center, Stanford

68198-3330

University of Nebraska Medical Center, Omaha

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Nebraska

OTHER

NCT00004197 - Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter